System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Johan Virhammar is an expert in Neurology at Uppsala University Hospital (Sweden). As of October 2026, ScienceLeadR ranks Johan Virhammar in the top 1% of experts worldwide for Hydrocephalus. Johan Virhammar has authored 50 publications, the most recent in 2026, and is an investigator in 2 clinical trials, 1 of them ongoing. SLR score: 251 (community average: 125). How the SLR is computed.

LeadR Profile

Johan Virhammar Uppsala University Hospital Sweden
251 ScienceLeadR Reputation 251

Unlock

Register Login
Network Map

Neurology

Subspecialties: Medical Imaging - Neurosurgery

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2011 - 2026
Source: PubMed

Uppsala University Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 50

Citations

Citations: 1 613 1st author: 15 Last author: 11 Unique author: 0

Main journals

Fluids Barriers CNS 10
AJNR Am J Neuroradiol 4
Eur J Neurol 4
J Neuroimaging 4
J Neurosurg 3

Best Journals

Lancet Neurol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Assessing CT-based volumetric analysis via deep learning for idiopathic normal pressure hydrocephalus.
PMID 42603074 — research design, brain, deep learning, hydrocephalus, normal pressure, learning, hydrocephalus		Brain Commun20260
Safety, tolerability, and efficacy of acetazolamide in idiopathic normal pressure hydrocephalus (DRAIN) in Sweden: a randomised, double-blind, placebo-controlled, phase 2 trial.
PMID 42127932 — acetazolamide, safety, gait, aged, drug-related side effects and adverse reactions, hydrocephalus, normal pressure, therapeutics, nervous system, hydrocephalus		Lancet Neurol Top journal20260
Pathological signatures of white matter lesions in multiple sclerosis versus stroke: a synthetic MRI study.
PMID 42017989 — white matter, sclerosis, multiple sclerosis, stroke, radiography, wounds and injuries		Neuroradiology20260
Rapid Estimation of Myelin for Diagnostic Imaging and Quantification of Therapy Responses in Multiple Sclerosis.
PMID 41685971 — sclerosis, multiple sclerosis, brain, multiple chronic conditions, diagnostic imaging, rituximab, therapeutics		J Neuroimaging20260
Targeted CSF metabolomics and conformal prediction improve diagnostic accuracy of normal pressure hydrocephalus.
PMID 41654915 — metabolomics, hydrocephalus, normal pressure, hydrocephalus		Fluids Barriers CNS20260

Clinical Studies 2

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

N/A 1
Phase 2 1

By status:

Completed 1
Recruiting 1

By type:

Interventional 1
Observational 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 1
multicentricup10 0

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
European Study of Prodromal iNPH
NCT05910944 — natural history, biomarkers, hydrocephalus, normal pressure, history, hydrocephalus		N/ARecruiting2023

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS